Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations, causing significant stock volatility. High trading volumes and sharp stock ...

I have been tracking purchase application data for over 14 years, and 2025 is likely the most confusing year for market participants that I have ever experienced. After today’s report of 22% year-over ...

PTC Therapeutics is a commercial stage biotechnology firm. Its last Phase 2 trial, investigating PTC518 in Huntington's disease, released mixed results about the drug efficacy. We think a Phase 3 ...